REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $714,434 | +70.6% | 7,007 | +52.1% | 0.04% | +46.2% |
| Q1 2023 | $418,778 | +64.2% | 4,606 | +81.9% | 0.03% | +188.9% |
| Q3 2021 | $255,000 | -34.8% | 2,532 | -8.4% | 0.01% | -30.8% |
| Q2 2021 | $391,000 | +73.0% | 2,763 | +51.4% | 0.01% | +30.0% |
| Q4 2020 | $226,000 | -26.1% | 1,825 | -6.9% | 0.01% | -41.2% |
| Q2 2020 | $306,000 | +1.7% | 1,960 | -6.1% | 0.02% | -26.1% |
| Q1 2020 | $301,000 | -36.2% | 2,087 | -9.6% | 0.02% | +9.5% |
| Q4 2019 | $472,000 | +60.5% | 2,308 | -35.7% | 0.02% | +90.9% |
| Q3 2018 | $294,000 | – | 3,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |